Cargando…
Prevalence and predictors of androgen receptor and programmed death-ligand 1 in BRCA1-associated and sporadic triple-negative breast cancer
BACKGROUND: Triple-negative breast cancers comprise 15% of breast cancers and are more common in women with BRCA1 mutations. Although most have basal gene expression signatures, others resemble luminal tumors with expression of androgen receptor-related genes and some express the immunoinhibitory pr...
Autores principales: | Tung, Nadine, Garber, Judy E, Hacker, Michele R, Torous, Vanda, Freeman, Gordon J, Poles, Emily, Rodig, Scott, Alexander, Brian, Lee, Larissa, Collins, Laura C, Schnitt, Stuart J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515333/ https://www.ncbi.nlm.nih.gov/pubmed/28721372 http://dx.doi.org/10.1038/npjbcancer.2016.2 |
Ejemplares similares
-
Retinoblastoma protein expression and its predictors in triple-negative breast cancer
por: Patel, Jaymin M., et al.
Publicado: (2020) -
BRCA1/2 testing: therapeutic implications for breast cancer management
por: Tung, Nadine M., et al.
Publicado: (2018) -
Patterns of recurrence and metastasis in BRCA1/BRCA2‐associated breast cancers
por: Song, Yun, et al.
Publicado: (2019) -
Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers
por: Tung, Nadine, et al.
Publicado: (2010) -
Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features
por: Tung, Nadine, et al.
Publicado: (2010)